Objectives

The specific objectives of WP5 are:

1. Provide solutions to store, curate, access, analyse and visualize large and highly dimensional datasets generated as part of the RTCure consortium. Data types described by WP participants that already exist or will be generated include but are not limited to: patient reported, clinical, genetic, epigenetic, transcriptomic, proteomic, microbiome, metabolomics, and immunophenotype

2. Collaborate with WPs 2, 3 and 4 to determine which of their data are in scope for WP5 and define an optimal data management and analysis plan to facilitate achievement of their analytical goals.

3. Utilize the developed insight, systems, and results from the above analyses to collaborate with WP6 on clinical trials with regard to

   • Analysis of selected datasets

   • Selection of biomarker assays

   • Patient segmentation

   • Treatment strategies

Partners

• KI

• DRFZ

• MUW

• UKER

• LUMC (lead)

• UQ

• ANOCCA

• Janssen

• UCB

• GSK

• Sanofi

• BMS

• PFIZER (lead)